Annual EBITDA
$1.02B$1.07B+2,304.65%
Summary
- Current Value
- As of today, ARGX annual EBITDA is $1.02B, up +2304.65% on
- Historical Performance
- ARGX annual EBITDA is up +259.28% over the past 3 years, up +307.92% over the past 5 years
- All-Time High Comparison
- ARGX annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- ARGX annual EBITDA is +259.28% above its 3-year low of -$641.62M reached on an earlier date
- Sector Comparison
- ARGX annual EBITDA is higher than 93.45% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.02B | +2304.7% | +259.3% | +307.9% | – | |
| Quarterly EBITDA | $438.00M | +148.9% | – | +297.4% | +10000.0% | |
| TTM EBITDA | $1.47B | +733.7% | – | +761.2% | +10000.0% | |
| Price | $806.45 | +37.2% | +100.6% | +195.7% | – | |
| PE Ratio | 75.37 | -66.9% | – | – | – | |
| Annual Revenue | $4.17B | +90.6% | +913.8% | +9935.4% | – | |
| Annual EPS | $19.63 | +53.8% | +250.3% | +245.5% | – | |
| $993.75M | +1656.4% | +233.2% | +300.6% | – | ||
| Annual Net Income | $1.30B | +55.9% | +282.5% | +311.6% | – |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.02B | at high | |
| 5Y | $1.02B | at high | |
| All | $1.02B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$641.62M | N/A | +259.3% |
| 5Y | -$641.62M | +259.3% | |
| All | -$641.62M | +259.3% |
EBITDA History
FAQ
What is the current annual EBITDA of ARGX?
As of today, ARGX annual EBITDA is $1.02B
What is 1-year change in ARGX annual EBITDA?
ARGX annual EBITDA is up +2304.65% year-over-year
What is 3-year change in ARGX annual EBITDA?
ARGX annual EBITDA is up +259.28% over the past 3 years
How far is ARGX annual EBITDA from its all-time high?
ARGX annual EBITDA is currently at its all-time high
How does ARGX annual EBITDA rank versus sector peers?
ARGX annual EBITDA is higher than 93.45% of companies in Healthcare sector
When is ARGX next annual earnings release?
As of today, the next annual earnings release for ARGX has not been scheduled
Quarterly EBITDA
$438.00M$37.10M+9.25%
Summary
- Current Value
- As of today, ARGX quarterly EBITDA is $438.00M, up +9.25% on
- Historical Performance
- ARGX quarterly EBITDA is up +148.86% year-over-year, with unknown 3-year change
- All-Time High Comparison
- ARGX quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- ARGX quarterly EBITDA is +148.86% above its 3-year low of $176.00M reached on
- Sector Comparison
- ARGX quarterly EBITDA is higher than 94.92% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $438.00M | +9.3% | +148.9% | – | +297.4% | |
| Annual EBITDA | $1.02B | – | +2304.7% | +259.3% | +307.9% | |
| TTM EBITDA | $1.47B | +21.7% | +733.7% | – | +761.2% | |
| Price | $806.45 | +4.5% | +37.2% | +100.6% | +195.7% | |
| PE Ratio | 75.37 | – | -66.9% | – | – | |
| Quarterly Revenue | $1.30B | +0.8% | +64.3% | – | +5444.2% | |
| Quarterly EPS | $5.52 | – | +114.0% | – | +226.6% | |
| $427.00M | +5.7% | +110.3% | – | +286.4% | ||
| Quarterly Net Income | $366.00M | -31.3% | +116.6% | – | +261.1% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $438.00M | at high | |
| 3Y | $438.00M | at high | |
| 5Y | $438.00M | at high | |
| All | $438.00M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $176.00M | N/A | +148.9% |
| 3Y | $176.00M | +148.9% | |
| 5Y | -$221.91M | +297.4% | |
| All | -$221.91M | +297.4% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ARGX?
As of today, ARGX quarterly EBITDA is $438.00M
What is ARGX quarterly EBITDA most recent change?
ARGX quarterly EBITDA was up +9.25% on March 31, 2026
What is 1-year change in ARGX quarterly EBITDA?
ARGX quarterly EBITDA is up +148.86% year-over-year
How far is ARGX quarterly EBITDA from its all-time high?
ARGX quarterly EBITDA is currently at its all-time high
How does ARGX quarterly EBITDA rank versus sector peers?
ARGX quarterly EBITDA is higher than 94.92% of companies in Healthcare sector
When is ARGX next earnings release?
The next earnings release for ARGX is on
TTM EBITDA
$1.47B$262.00M+21.74%
Summary
- Current Value
- As of today, ARGX TTM EBITDA is $1.47B, up +21.74% on
- Historical Performance
- ARGX TTM EBITDA is up +733.67% year-over-year, with unknown 3-year change
- All-Time High Comparison
- ARGX TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- ARGX TTM EBITDA is +733.67% above its 3-year low of $176.00M reached on
- Sector Comparison
- ARGX TTM EBITDA is higher than 94.27% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $1.47B | +21.7% | +733.7% | – | +761.2% | |
| Annual EBITDA | $1.02B | – | +2304.7% | +259.3% | +307.9% | |
| Quarterly EBITDA | $438.00M | +9.3% | +148.9% | – | +297.4% | |
| Price | $806.45 | +4.5% | +37.2% | +100.6% | +195.7% | |
| PE Ratio | 75.37 | – | -66.9% | – | – | |
| TTM Revenue | $4.66B | +12.2% | +490.0% | – | +10000.0% | |
| TTM EPS | $10.70 | – | +314.7% | – | +345.4% | |
| $1.51B | +17.5% | +642.0% | – | +757.4% | ||
| TTM Net Income | $1.49B | +15.3% | +780.8% | – | +755.2% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.47B | at high | |
| 3Y | $1.47B | at high | |
| 5Y | $1.47B | at high | |
| All | $1.47B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $176.00M | N/A | +733.7% |
| 3Y | $176.00M | +733.7% | |
| 5Y | -$391.54M | +474.7% | |
| All | -$391.54M | +474.7% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ARGX?
As of today, ARGX TTM EBITDA is $1.47B
What is ARGX TTM EBITDA most recent change?
ARGX TTM EBITDA was up +21.74% on March 31, 2026
What is 1-year change in ARGX TTM EBITDA?
ARGX TTM EBITDA is up +733.67% year-over-year
How far is ARGX TTM EBITDA from its all-time high?
ARGX TTM EBITDA is currently at its all-time high
How does ARGX TTM EBITDA rank versus sector peers?
ARGX TTM EBITDA is higher than 94.27% of companies in Healthcare sector
When is ARGX next earnings release?
The next earnings release for ARGX is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- ARGX Official Website argenx.com
- ARGX Profile on Yahoo Finance finance.yahoo.com/quote/ARGX
- ARGX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/argx